Profile | GDS4284 / 1555358_a_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 549.225 | 65 |
GSM687648 | Patient 402 control | 599.151 | 66 |
GSM687653 | Patient 403 control | 384.396 | 60 |
GSM687658 | Patient 404 control | 320.838 | 57 |
GSM687663 | Patient 411 control | 406.077 | 60 |
GSM687668 | Patient 422 control | 438.144 | 62 |
GSM687673 | Patient 424 control | 980.949 | 73 |
GSM687678 | Patient 425 control | 591.19 | 65 |
GSM687683 | Patient 427 control | 225.116 | 49 |
GSM687688 | Patient 428 control | 1269.14 | 77 |
GSM687695 | Patient 441 control | 326.895 | 51 |
GSM687699 | Patient 443 control | 508.27 | 63 |
GSM687704 | Patient 444 control | 466.962 | 63 |
GSM687707 | Patient 448 control | 1030.28 | 75 |
GSM687712 | Patient 449 control | 415.872 | 60 |
GSM687719 | Patient 450 control | 650.926 | 67 |
GSM687724 | Patient 451 control | 394.684 | 60 |
GSM687728 | Patient 452 control | 787.209 | 71 |
GSM687646 | Patient 401 treated 24h | 428.703 | 61 |
GSM687649 | Patient 402 treated 24h | 711.456 | 69 |
GSM687665 | Patient 411 treated 24h | 335.076 | 56 |
GSM687651 | Patient 402 treated 4 weeks | 597.856 | 66 |
GSM687667 | Patient 411 treated 4 weeks | 473.594 | 62 |
GSM687670 | Patient 422 treated 24h | 585.92 | 65 |
GSM687671 | Patient 422 treated 4 weeks | 595.592 | 66 |
GSM687654 | Patient 403 treated 24h | 389.17 | 61 |
GSM687675 | Patient 424 treated 24h | 907.783 | 72 |
GSM687685 | Patient 427 treated 24h | 394.14 | 60 |
GSM687656 | Patient 403 treated 4 weeks | 523.501 | 65 |
GSM687677 | Patient 424 treated 4 weeks | 909.83 | 72 |
GSM687687 | Patient 427 treated 4 weeks | 444.146 | 62 |
GSM687692 | Patient 428 treated 4h | 652.571 | 67 |
GSM687716 | Patient 449 treated 4h | 453.69 | 63 |
GSM687722 | Patient 450 treated 4h | 287.239 | 53 |
GSM687680 | Patient 425 treated 24h | 643.628 | 67 |
GSM687690 | Patient 428 treated 24h | 732.665 | 70 |
GSM687700 | Patient 443 treated 24h | 305.28 | 50 |
GSM687705 | Patient 444 treated 24h | 177.958 | 48 |
GSM687714 | Patient 449 treated 24h | 332.154 | 58 |
GSM687721 | Patient 450 treated 24h | 332.725 | 55 |
GSM687682 | Patient 425 treated 4 weeks | 412.94 | 61 |
GSM687694 | Patient 428 treated 4 weeks | 621.015 | 67 |
GSM687702 | Patient 443 treated 4 weeks | 347.712 | 56 |
GSM687718 | Patient 449 treated 4 weeks | 411.3 | 61 |
GSM687723 | Patient 450 treated 4 weeks | 339.086 | 57 |
GSM687661 | Patient 404 treated 4h | 278.083 | 53 |
GSM687710 | Patient 448 treated 4h | 779.567 | 71 |
GSM687726 | Patient 451 treated 4h | 431.837 | 60 |
GSM687730 | Patient 452 treated 4h | 17.3777 | 1 |
GSM687660 | Patient 404 treated 24h | 166.593 | 40 |
GSM687697 | Patient 441 treated 24h | 419.659 | 58 |
GSM687709 | Patient 448 treated 24h | 1222.33 | 77 |
GSM687725 | Patient 451 treated 24h | 524.119 | 64 |
GSM687729 | Patient 452 treated 24h | 614.906 | 68 |
GSM687727 | Patient 451 treated 4 weeks | 611.775 | 66 |
GSM687731 | Patient 452 treated 4 weeks | 805.103 | 71 |